Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
<p>Figure S2. Lurbinectedin sensitivity (IC50) correlation with MYC expression and changes in expression of NE markers.</p>
Enregistré dans:
| Auteur principal: | Subhamoy Chakraborty (16648124) (author) |
|---|---|
| Autres auteurs: | Charles Coleman (16648127) (author), Parvathy Manoj (16648130) (author), Deniz Demircioglu (15306139) (author), Nisargbhai Shah (16648133) (author), Elisa de Stanchina (14954757) (author), Charles M. Rudin (11572933) (author), Dan Hasson (15306151) (author), Triparna Sen (14126577) (author) |
| Publié: |
2025
|
| Sujets: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Figure S1 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
par: Subhamoy Chakraborty (16648124)
Publié: (2025) -
Figure S3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
par: Subhamoy Chakraborty (16648124)
Publié: (2025) -
Supplementary Tables 1-3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
par: Subhamoy Chakraborty (16648124)
Publié: (2025) -
Filamin A KO and S2152A KI reduce KSHV de novo infection of cell-free virions.
par: Xiaojuan Li (351842)
Publié: (2025) -
Filamin A KO and S2152A KI reduce KSHV de novo infection and cell-contact mediated viral infection.
par: Xiaojuan Li (351842)
Publié: (2025)